查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601055

间质干细胞市场：按类型、适应症、分离来源、应用分类 - 2025-2030 年全球预测

Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

间质干细胞市场2023年估值为35.1亿美元，预计到2024年将达到39.8亿美元，复合年增长率为13.63%，预计到2030年将达到85.9亿美元。

间质干细胞（MSC）是多功能基质细胞，可分化成各种细胞类型，包括骨头、软骨和脂肪。间质干细胞在再生医学的应用范围非常广泛，其在组织工程、自体免疫疾病治疗及其在调节免疫反应中的作用的潜在应用就是例证。主要应用包括心血管、整形外科和神经系统疾病的再生治疗。製药、生物技术和医疗保健等行业是 MSC 技术的主要最终应用领域。面对慢性疾病的增加和人口老化，对创新治疗方法的需求不断增长，这凸显了对间质干细胞的需求，刺激了基于间质干细胞的新型产品的研究和投资。市场成长主要受到干细胞治疗技术进步、研究经费增加以及支持再生医学的有利政府法规的推动。学术界和生技公司之间不断加强的研究合作进一步凸显了突破性治疗方法的潜力。然而，诸如严格的监管核准、基于间质干细胞的治疗方法的高成本、伦理问题以及干细胞分化和扩增的技术困难等挑战可能会阻碍市场的进步。此外，可变的临床结果和可扩展性问题也带来了额外的障碍。创新的关键领域包括增强干细胞功效和输送机制、开发可扩展的製造流程以及建构即时生理监测平台。随着 MSC 市场的发展，研发方面的策略性投资、强调遵守法规结构以及建立技术共用伙伴关係对于持续成长至关重要。总体而言，间质干细胞代表了再生医学领域一个充满希望但充满挑战的前沿领域，对于那些能够驾驭复杂的临床、监管和市场格局的人来说具有巨大的潜力。

主要市场统计
基准年[2023] 35.1亿美元
预测年份 [2024] 39.8亿美元
预测年份 [2030] 85.9亿美元
复合年增长率（%） 13.63%

市场动态：快速发展的间质干细胞市场的关键市场洞察

供需的动态交互作用正在改变间间质干细胞市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 基于间质干细胞的研究的发展
    • 老年人口增加和慢性病增加
    • 干细胞治疗不断发展的前景
  • 市场限制因素
    • 干细胞治疗缺乏标准化和监管
  • 市场机会
    • 间质干细胞的新应用
    • 扩大间间质干细胞产品的合作研究和伙伴关係并推动治疗创新
  • 市场挑战
    • 与间质干细胞治疗相关的伦理和安全问题

波特的五力：驾驭间质干细胞市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解间质干细胞市场的外部影响

外部宏观环境因素在塑造间质干细胞市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解间质干细胞市场的竞争状况

对间质干细胞市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位间质干细胞市场供应商绩效评估

FPNV定位矩阵是评估间质干细胞市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 间质干细胞的生长研究
      • 老年人口增加和慢性病增加
      • 干细胞治疗的持续前景
    • 抑制因素
      • 干细胞治疗缺乏标准化和监管
    • 机会
      • 间质干细胞的新应用
      • 扩大间间质干细胞产品合作和伙伴关係并推动治疗创新
    • 任务
      • 与人类 MSC 治疗相关的伦理和安全问题
  • 市场区隔分析
    • 类型：自体间质干细胞的免疫安全性和个人化使其有利于长期治疗
    • 适应症：用于 CVD 治疗的 MSC 的大量研发活动
    • 分离来源：骨髓间质干细胞的高细胞产量和已建立的治疗用途
    • 应用：间质干细胞由于能够模拟人类疾病和测试药物疗效，在疾病建模和药物发现方面具有优势
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

间质干细胞市场：依类型

  • 同种异体的
  • 自体移植

间质干细胞市场的适应症

  • 骨头和软骨修復
  • 癌症
  • 心血管疾病
  • 移植物抗宿主疾病
  • 发炎和免疫疾病
  • 肝臟疾病

间质干细胞市场依来源隔离

  • 脂肪组织
  • 骨髓
  • 脐带血
  • 输卵管
  • 胎儿肝臟
  • 肺
  • 週边血

间质干细胞市场：依应用分类

  • 疾病模型
  • 药物开发和发现
  • 干细胞银行
  • 组织工程
  • 毒理学研究

第十章 北美及南美间间质干细胞市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区间间质干细胞市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲间间质干细胞市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Cellcolabs 宣布与 REPROCELL 合作
    • PromoCell 推出 PromoExQ MSC 生长培养基 XF，用于符合 GMP 的间质干细胞分离与扩增
    • Pluristyx 和 Stemmatters 宣布合作开发和製造 iPSC 衍生的 MSC 银行

公司名单

  • PromoCell GmbH
  • Globus Medical
  • Pluri Biotech Ltd.
  • ScienCell Research Laboratories, Inc.
  • Stemedica Cell Technologies, Inc.
  • Cyagen Biosciences, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Stemcell Technologies Inc.
  • AMS Biotechnology
  • Mesoblast Limited
  • Thermo Fisher Scientific, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Genlantis, Inc.
  • Celprogen, Inc.
  • Takeda Pharmaceutical Company Limited
  • Athersys, Inc.
  • R&D Systems, Inc.
  • Smith & Nephew PLC
  • Cytori Therapeutics Inc.
  • Axol Biosciences Ltd.
  • Neuromics
  • Vericel Corporation
  • Hope Biosciences, LLC
  • Cell Applications, Inc.
  • Astellas Pharma Inc.
Product Code: MRR-B973EDD5ED66

The Mesenchymal Stem Cells Market was valued at USD 3.51 billion in 2023, expected to reach USD 3.98 billion in 2024, and is projected to grow at a CAGR of 13.63%, to USD 8.59 billion by 2030.

Mesenchymal Stem Cells (MSCs) are multipotent stromal cells capable of differentiating into various cell types, including bone, cartilage, and fat. The scope of MSCs in regenerative medicine is vast, epitomized by their potential use in tissue engineering, the treatment of autoimmune diseases, and their role in modulating immune responses. Key applications include regenerative treatments for cardiovascular, orthopedic, and neurological disorders. Industries such as pharmaceuticals, biotechnology, and healthcare are primary end-use sectors for MSC technologies. The necessity of MSCs is underscored by the growing demand for innovative therapies in the face of rising chronic diseases and an aging population, fueling research and investments in novel MSC-based products. Market growth is significantly influenced by technological advancements in stem cell therapy, increased funding for research, and favorable government regulations supporting regenerative medicine, thereby creating opportunities for new market entrants and existing players to expand their offerings. The rise in collaborations between academia and biotech firms further accentuates the potential for groundbreaking therapies. However, challenges such as stringent regulatory approvals, high costs of MSC-based therapies, ethical concerns, and technical difficulties in stem cell differentiation and proliferation can impede market progress. Moreover, the varied clinical outcomes and scalability issues pose additional hurdles. Key areas of innovation include enhancing MSC potency and delivery mechanisms, developing scalable manufacturing processes, and creating platforms for real-time physiological monitoring. As the MSC market evolves, strategic investments in R&D, emphasis on compliance with regulatory frameworks, and the establishment of partnerships for technology sharing will be critical for sustained growth. Overall, MSCs present a promising yet challenging frontier in regenerative medicine, with remarkable potential for those capable of navigating the complex clinical, regulatory, and market landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.98 billion
Forecast Year [2030] USD 8.59 billion
CAGR (%) 13.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mesenchymal Stem Cells Market

The Mesenchymal Stem Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth in Mesenchymal Stem Cell-Based Research
    • Rising Geriatric Population Coupled with Growth in Chronic Diseases
    • Continuously Evolving Landscape of Stem Cell Therapies
  • Market Restraints
    • Lack of Standardized and Regulated Delivery of Stem Cell Therapy
  • Market Opportunities
    • Emerging Applications of Mesenchymal Stem Cells
    • Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
  • Market Challenges
    • Ethical & Safety Issues Associated with Human MSC Therapy

Porter's Five Forces: A Strategic Tool for Navigating the Mesenchymal Stem Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mesenchymal Stem Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mesenchymal Stem Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mesenchymal Stem Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mesenchymal Stem Cells Market

A detailed market share analysis in the Mesenchymal Stem Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mesenchymal Stem Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mesenchymal Stem Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Mesenchymal Stem Cells Market, highlighting leading vendors and their innovative profiles. These include PromoCell GmbH, Globus Medical, Pluri Biotech Ltd., ScienCell Research Laboratories, Inc., Stemedica Cell Technologies, Inc., Cyagen Biosciences, Inc., BrainStorm Cell Therapeutics Inc., Stemcell Technologies Inc., AMS Biotechnology, Mesoblast Limited, Thermo Fisher Scientific, Inc., Lonza Group AG, Merck KGaA, Genlantis, Inc., Celprogen, Inc., Takeda Pharmaceutical Company Limited, Athersys, Inc., R&D Systems, Inc., Smith & Nephew PLC, Cytori Therapeutics Inc., Axol Biosciences Ltd., Neuromics, Vericel Corporation, Hope Biosciences, LLC, Cell Applications, Inc., and Astellas Pharma Inc..

Market Segmentation & Coverage

This research report categorizes the Mesenchymal Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allogeneic and Autologous.
  • Based on Indication, market is studied across Bone & Cartilage Repair, Cancer, Cardiovascular Disease, GvHD, Inflammatory & Immunological Disease, and Liver Diseases.
  • Based on Source of Isolation, market is studied across Adipose Tissues, Bone Marrow, Cord Blood, Fallopian Tube, Fetal Liver, Lung, and Peripheral Blood.
  • Based on Application, market is studied across Disease Modeling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, and Toxicology Studies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in Mesenchymal Stem Cell-Based Research
      • 5.1.1.2. Rising Geriatric Population Coupled with Growth in Chronic Diseases
      • 5.1.1.3. Continuously Evolving Landscape of Stem Cell Therapies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Standardized and Regulated Delivery of Stem Cell Therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Applications of Mesenchymal Stem Cells
      • 5.1.3.2. Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical & Safety Issues Associated with Human MSC Therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Immunological safety and personalized nature of autologous MSCs to make them beneficial for long-term treatments
    • 5.2.2. Indication: Substantial research and development activities on MSCs for the treatment of CVDs
    • 5.2.3. Source of Isolation: High cell yield and established therapeutic use of bone-marrow derived MSC
    • 5.2.4. Application: Benefits of MSCs in disease modeling and drug discovery due to their ability to mimic human diseases and test drug efficacy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Mesenchymal Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic
  • 6.3. Autologous

7. Mesenchymal Stem Cells Market, by Indication

  • 7.1. Introduction
  • 7.2. Bone & Cartilage Repair
  • 7.3. Cancer
  • 7.4. Cardiovascular Disease
  • 7.5. GvHD
  • 7.6. Inflammatory & Immunological Disease
  • 7.7. Liver Diseases

8. Mesenchymal Stem Cells Market, by Source of Isolation

  • 8.1. Introduction
  • 8.2. Adipose Tissues
  • 8.3. Bone Marrow
  • 8.4. Cord Blood
  • 8.5. Fallopian Tube
  • 8.6. Fetal Liver
  • 8.7. Lung
  • 8.8. Peripheral Blood

9. Mesenchymal Stem Cells Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Modeling
  • 9.3. Drug Development & Discovery
  • 9.4. Stem Cell Banking
  • 9.5. Tissue Engineering
  • 9.6. Toxicology Studies

10. Americas Mesenchymal Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mesenchymal Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mesenchymal Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cellcolabs Announces Partnership With REPROCELL for Research And GMP Grade MSC And MSC Derivatives
    • 13.3.2. PromoCell Launches PromoExQ MSC Growth Medium XF for GMP-Compliant Isolation and Expansion of Mesenchymal Stem Cells
    • 13.3.3. Pluristyx and Stemmatters Announce Partnership to Develop and Manufacture iPSC-derived MSC Banks

Companies Mentioned

  • 1. PromoCell GmbH
  • 2. Globus Medical
  • 3. Pluri Biotech Ltd.
  • 4. ScienCell Research Laboratories, Inc.
  • 5. Stemedica Cell Technologies, Inc.
  • 6. Cyagen Biosciences, Inc.
  • 7. BrainStorm Cell Therapeutics Inc.
  • 8. Stemcell Technologies Inc.
  • 9. AMS Biotechnology
  • 10. Mesoblast Limited
  • 11. Thermo Fisher Scientific, Inc.
  • 12. Lonza Group AG
  • 13. Merck KGaA
  • 14. Genlantis, Inc.
  • 15. Celprogen, Inc.
  • 16. Takeda Pharmaceutical Company Limited
  • 17. Athersys, Inc.
  • 18. R&D Systems, Inc.
  • 19. Smith & Nephew PLC
  • 20. Cytori Therapeutics Inc.
  • 21. Axol Biosciences Ltd.
  • 22. Neuromics
  • 23. Vericel Corporation
  • 24. Hope Biosciences, LLC
  • 25. Cell Applications, Inc.
  • 26. Astellas Pharma Inc.

LIST OF FIGURES

  • FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. MESENCHYMAL STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MESENCHYMAL STEM CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 200. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023